LPA5 antagonist 3
LPA5 antagonist 3 (Example 74) is a lysophosphatidic acid receptor 5 (LPA5) antagonist, with an IC50 of 170 nM. LPA5 antagonist 3 can be used for the research of pain disorders and atherosclerosis[1].
Product Specifications
CAS Number
[1664336-44-0]
UNSPSC
12352005
Target
LPL Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/lpa5-antagonist-3.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC=C(CN(CC(F)(C)F)C(C2=CC=C(C=C2)OC3=C(F)C=CC=C3)=O)C=C1)O
Molecular Formula
C24H20F3NO4
Molecular Weight
443.42
References & Citations
[1]BUFFHAM W, et al. Amide derivatives as lysophosphatidic acid receptor antagonists. WO2015025164A1. 2015-02-26.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7019273-01 0.02 mg
Recombinant Cellvibrio japonicus Lipoprotein signal peptidase (lspA)
Ask
View Details MBS7019273-02 0.1 mg
Recombinant Cellvibrio japonicus Lipoprotein signal peptidase (lspA)
Ask
View Details MBS7019273-03 5x 0.1 mg
Recombinant Cellvibrio japonicus Lipoprotein signal peptidase (lspA)
Ask
View Details 